Capsule Endoscopy in Inflammatory Bowel Disease (IBD) in Children
Completed · Not applicable
Conditions studied: IBD
In brief
Most of the studies evaluating the roles of MRE and WCE conducted in pediatric patients have been retrospective with the main goal of making a diagnosis in patients with suspected IBD. The current study is the first prospective study in children with known IBD assessing the roles of MRE and WCE in identifying disease exacerbation. This study will help to identify if capsule endoscopy is superior or complementary to MRE in the evaluation of suspected disease exacerbation in IBD patients.
Key facts
- Study ID
- NCT02182947
- Run by
- Children's Mercy Hospital Kansas City
- People needed
- 45
- Starts
- 2012-08-01
- Expected to finish
- 2018-12-30
- Last updated by the study team
- 2021-03-11
Who can join
Age: 4 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aged 4 to 17.99 years at time of investigation
- IBD/CD and IBD/IC diagnosed based on standard clinical - histologic criteria
- Patient is scheduled to have MRE as standard of care for evaluation of disease severity/ complication.
- Signed permission/assent/consent
You may not qualify if…
- IBD diagnosis not established
- Recent intestinal tract surgery / resection involving small bowel
- Use of NSAIDs 4 weeks prior to the Capsule endoscopy study.
- Patients are on prokinetic medication.
- Swallowing disorders, esophageal stricture or patients unable to swallow the capsule.
- Presence of gastrointestinal obstruction or ileus.
- Patient with implanted electro-medical device or pacemakers.
Where it is running
- Children Mercy Hospital and Clinics — Kansas City, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.